ANDREW MAKRIDES
CIK 1280517 · CEO · last filed 2023-08-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.65M
Companies
2
Total Filings
18
Lifetime Open-Market Net
-$968.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| APYX | Director | 637,972 | $4.15 | $2.65M | $0 | 6 | 2023-08-15 |
| Apyx Medical Corp (BVX) Delisted | CEO | 605,972 | — | — | -$968.1K | 12 | 2018-11-09 |
Recent Filings · Page 2 of 2
18 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-07-19 | Apyx Medical Corp (BVX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-05-28 | Apyx Medical Corp (BVX) Delisted | Sell (S) | −57,500 | -$406.2K | EDGAR |
| 2009-05-26 | Apyx Medical Corp (BVX) Delisted | Sell (S) | −47,500 | -$341.1K | EDGAR |
| 2008-12-18 | Apyx Medical Corp (BVX) Delisted | Gift (G) | −4,500 | -$28.0K | EDGAR |
| 2008-12-08 | Apyx Medical Corp (BVX) Delisted | Mixed | +219,491 | -$0 | EDGAR |
| 2008-01-07 | Apyx Medical Corp (BVX) Delisted | Mixed | +132,422 | $1 | EDGAR |
| 2007-02-01 | Apyx Medical Corp (BVX) Delisted | Gift (G) | −4,000 | $0 | EDGAR |
| 2007-01-16 | Apyx Medical Corp (BVX) Delisted | Sell (S) | −25,000 | -$220.8K | EDGAR |
Showing 11–18 of 18
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.